| 000 | 01126 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512144924.0 | ||
| 264 | 0 | _c19720611 | |
| 008 | 197206s 0 0 eng d | ||
| 022 | _a0014-4754 | ||
| 024 | 7 |
_a10.1007/BF02154280 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSelye, H | |
| 245 | 0 | 0 |
_aEffect of catatoxic steroids upon established morbid changes. _h[electronic resource] |
| 260 |
_bExperientia _cDec 1971 |
||
| 300 |
_a1445-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDigitoxin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIndomethacin _xadverse effects |
| 650 | 0 | 4 |
_aIntestine, Small _xpathology |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aPeritonitis _xchemically induced |
| 650 | 0 | 4 |
_aPoisoning _xdrug therapy |
| 650 | 0 | 4 |
_aPregnenolone _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 650 | 0 | 4 |
_aSpironolactone _xadministration & dosage |
| 773 | 0 |
_tExperientia _gvol. 27 _gno. 12 _gp. 1445-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02154280 _zAvailable from publisher's website |
| 999 |
_c5147090 _d5147090 |
||